Literature DB >> 17477480

Consensus on a core set of domains for psoriatic arthritis.

Dafna D Gladman, Philip J Mease, Vibeke Strand, Paul Healy, Philip S Helliwell, Oliver Fitzgerald, Alice B Gottlieb, Gerald G Krueger, Peter Nash, Christopher T Ritchlin, William Taylor, Ade Adebajo, Jurgen Braun, Alberto Cauli, Sueli Carneiro, Ernst Choy, Ben Dijkmans, Luiz Espinoza, Desiree van der Heijde, Elaine Husni, Ennio Lubrano, Dennis McGonagle, Abrar Qureshi, Enrique R Soriano, Jane Zochling.   

Abstract

A psoriatic arthritis (PsA) module was convened at OMERACT 8 in order to achieve consensus on the core domains that should be included in randomized controlled trials and longitudinal observational cohorts of subjects with PsA. Following a plenary session at which current status of measures used to assess PsA were reviewed, and discussion at breakout groups, the group achieved consensus on 6 core domains: peripheral joint activity, skin activity, pain, patient global assessment, physical function, and health-related quality of life. In addition the following domains were considered important but not mandatory: spinal disease, dactylitis, enthesitis, fatigue, nail disease, radiography, physician global assessment, and acute-phase reactants. A research agenda was proposed to include development and validation of instruments for the domains where none existed, and in particular further research was recommended for the following areas: magnetic resonance imaging and ultrasound of joints, enthesitis, skin and synovial tissue analysis, and "participation."

Entities:  

Mesh:

Year:  2007        PMID: 17477480

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  73 in total

Review 1.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

2.  Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison.

Authors:  Philip Mease; Ernest Choy; Peter Nash; Chrysostomos Kalyvas; Matthias Hunger; Luminita Pricop; Kunal K Gandhi; Steffen M Jugl; Howard Thom
Journal:  Eur J Rheumatol       Date:  2018-07-01

3.  [Treatment recommendations for psoriatic arthritis].

Authors:  W-H Boehncke
Journal:  Z Rheumatol       Date:  2009-12       Impact factor: 1.372

Review 4.  Treat to target in psoriatic arthritis-evidence, target, research agenda.

Authors:  Laura C Coates; Philip S Helliwell
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

Review 5.  Application of the GRAPPA psoriatic arthritis treatment recommendations in clinical practice.

Authors:  Aizad Mumtaz; Oliver FitzGerald
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

6.  Gender does not make a difference in "composite psoriatic disease activity index (CPDAI)" in patients with psoriatic arthritis.

Authors:  Gökçe Kenar; Handan Yarkan; Berrin Zengin; Gerçek Can; Merih Birlik; Fatoş Önen
Journal:  Rheumatol Int       Date:  2018-09-08       Impact factor: 2.631

Review 7.  [Psoriatic arthritis. Treatment outcome parameters].

Authors:  E Märker-Hermann; F Behrens
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372

8.  Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting.

Authors:  Ana-Maria Orbai; Philip J Mease; Maarten de Wit; Umut Kalyoncu; Willemina Campbell; William Tillett; Lihi Eder; Musaab Elmamoun; Oliver FitzGerald; Dafna D Gladman; Niti Goel; Laure Gossec; Chris A Lindsay; Ingrid Steinkoenig; Philip S Helliwell; Neil J McHugh; Vibeke Strand; Alexis Ogdie
Journal:  J Rheumatol       Date:  2016-05       Impact factor: 4.666

Review 9.  Patient-reported outcomes in core domain sets for rheumatic diseases.

Authors:  Lilian H D van Tuyl; Maarten Boers
Journal:  Nat Rev Rheumatol       Date:  2015-09-01       Impact factor: 20.543

Review 10.  Treatment recommendations for psoriatic arthritis.

Authors:  C T Ritchlin; A Kavanaugh; D D Gladman; P J Mease; P Helliwell; W-H Boehncke; K de Vlam; D Fiorentino; O Fitzgerald; A B Gottlieb; N J McHugh; P Nash; A A Qureshi; E R Soriano; W J Taylor
Journal:  Ann Rheum Dis       Date:  2008-10-24       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.